| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5899181 | Diabetes Research and Clinical Practice | 2015 | 29 Pages |
Abstract
Most ISs in combination with metformin were associated with similar mortality and cardiovascular risk. Whether glipizide is associated with increased risk compared with other ISs when used in combinations with metformin warrants further study.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Ulrik Madvig Mogensen, Charlotte Andersson, Emil Loldrup Fosbøl, Tina Ken Schramm, Allan Vaag, Nikolai Madrid Scheller, Christian Torp-Pedersen, Gunnar Gislason, Lars Køber,